Dishman Pharmaceuticals Q3 net rises 10-fold
Dishman Pharmaceuticals and Chemicals today reported nearly 10-fold increase in its consolidated net profit at Rs 16.72 crore for the quarter ended December 31.
By PTI | Updated:
MUMBAI: Dishman Pharmaceuticals and Chemicals today reported nearly 10-fold increase in its consolidated net profit at Rs 16.72 crore for the quarter ended December 31.
The company had posted a net profit of Rs 1.68 crore in the corresponding period last financial year.
The consolidated total income during the quarter under review also went up by 11.89 per cent to Rs 266.19 crore from Rs 237.89 crore in the year-ago period, Dishman Pharmaceuticals and Chemicals said in a filing to the BSE.
Reacting to the numbers, shares of the company closed higher by 8.32 per cent at Rs 59.90 on the BSE.
The company had posted a net profit of Rs 1.68 crore in the corresponding period last financial year.
The consolidated total income during the quarter under review also went up by 11.89 per cent to Rs 266.19 crore from Rs 237.89 crore in the year-ago period, Dishman Pharmaceuticals and Chemicals said in a filing to the BSE.
Reacting to the numbers, shares of the company closed higher by 8.32 per cent at Rs 59.90 on the BSE.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
